[Dendritic cell-based immunotherapy for multiple myeloma — review]
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-06-01 / Zhongguo Shi Yan Xue Ye Xue Za Zhi 2009 Jun;17(3):821-5Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2009-06-01 / Scand. J. Immunol. 2009 Jun;69(6):529-36Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy
/in Dendritic Cells, International Publications, Pancreatic Cancer /von 2009-06-01 / Int. J. Oncol. 2009 Jun;34(6):1701-15Dendritic cell-based cancer immunotherapies
/in Dendritic Cells, International Publications /von 2009-05-29 / Arch. Immunol. Ther. Exp. (Warsz.) 2009 May-Jun;57(3):189-98Comparative analysis of DC fused with allogeneic hepatocellular carcinoma cell line HepG2 and autologous tumor cells as potential cancer vaccines against hepatocellular carcinoma
/in Dendritic Cells, Hepatocellular Carcinoma, International Publications /von 2009-05-27 / Cell. Immunol. 2009;259(1):13-20On immunotherapies and cancer vaccination protocols: a mathematical modelling approach
/in Dendritic Cells, International Publications /von 2009-05-14 / J. Theor. Biol. 2009 Aug;259(4):820-7Vaccination with multiple peptides derived from novel cancer-testis antigens can induce specific T-cell responses and clinical responses in advanced esophageal cancer
/in Dendritic Cells, Esophageal Carcinoma, International Publications /von 2009-05-14 / Cancer Sci. 2009 Aug;100(8):1502-9Increases in serum TARC/CCL17 levels are associated with progression-free survival in advanced melanoma patients in response to dendritic cell-based immunotherapy
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-07 / J. Clin. Immunol. 2009 Sep;29(5):657-64Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-05-05 / Clin. Cancer Res. 2009 May;15(10):3366-75
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de